U.S. Revenue Cycle Management For Oncology And Urology Market Projected To Reach USD 22.3 Billion By 2030
San Francisco, 23 March 2023: The Report U.S. Revenue Cycle Management for Oncology And Urology Market Size, Share & Trends Analysis Report By Sourcing (In-house, External RCM Apps/ Software, Outsourced RCM Services), By End Use, And Segment Forecasts, 2023 - 2030 The U.S. revenue cycle management for oncology and urology market is expected to reach USD 22.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.7% from 2023 to 2030. The market growth can be attributed to the rising adoption of applications that would help in streamlining revenue cycles for various healthcare institutions and technological advancements undertaken by the key players in the market. Developers and vendors of RCM platforms & solutions are supporting healthcare facilities in accommodating and getting themselves accustomed to the transitions associated with ICD-10. RCM providers are focusing on increasing staff resources & pr